Laborbezogene Publikationen aus 2011:
Original Artikel mit dem Titel:
- A. Piechota-Polanczyk, A. Goraca, S. Demyanets, M. Mittlboeck, C. Domenig, C. Neumayer, J. Wojta, J. Nanobachvili, I. Huk and M. Klinger. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-?B. European Journal of Vascular and Endovascular Surgery (under revision).
- Demyanets S, Konya V, Kastl SP, Kaun C, Rauscher S, Niessner A, Pentz R, Pfaffenberger S, Rychli K, Lemberger CE, de Martin R, Heinemann A, Huk I, Gröger M, Maurer G, Huber K, Wojta J. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9.
- Demyanets S, Kaun C, Rychli K, Pfaffenberger S, Kastl SP, Hohensinner PJ, Rega G, Katsaros KM, Afonyushkin T, Bochkov VN, Paireder M, Huk I, Maurer G, Huber K, Wojta J. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-?. Basic Res Cardiol. 2011 Mar;106(2):217-31.
Angabe von abgeschlossenen Habilitationen, Dissertationen, Diplomarbeiten aus 2011
- Habilitation von Priv. Doz. Dr. Markus Klinger am 28.6.2011:
„Targeted Tumor Therapy via Growth Factor and G-protein Coupled Receptor Signaling Components: Ex- and In-vivo Studies”